Copyright
©The Author(s) 2021.
World J Gastroenterol. Nov 7, 2021; 27(41): 7159-7172
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7159
Published online Nov 7, 2021. doi: 10.3748/wjg.v27.i41.7159
Table 1 Patient demographic and clinical characteristics
All patients | Propensity-score matched patients | |||||
Open (n = 211) | Laparoscopy (n = 137) | P | Open (n = 102) | Laparoscopy (n = 102) | SMD | |
Age (yr) | 29.2 ± 9.7 | 29.2 ± 9.0 | 0.976 | 28.8 ± 9.0 | 28.6 ± 8.7 | -0.026 |
Gender, male | 153 (72.5) | 95 (69.3) | 0.546 | 78 (76.5) | 72 (70.6) | -0.134 |
BMI (kg/m2) | 18.8 ± 3.2 | 18.9 ± 2.8 | 0.822 | 19.0 ± 3.3 | 18.9 ± 2.8 | -0.041 |
Any smoking history | 41 (19.4) | 33 (24.1) | 0.348 | 21 (20.6) | 20 (19.6) | -0.025 |
Previous abdominal surgery | 23 (10.9) | 10 (7.3) | 0.349 | 10 (9.8) | 8 (7.8) | -0.069 |
Montreal classification | ||||||
Behavior | < 0.001 | -0.044 | ||||
Inflammatory (B1) | 2 (0.1) | 2 (1.5) | 2 (2.0) | 2 (2.0) | ||
Stricturing (B2) | 38 (17.5) | 52 (38.0) | 30 (29.4) | 26 (25.5) | ||
Penetrating (B3) | 172 (82.0) | 83 (60.6) | 70 (68.6) | 74 (72.5) | ||
Location | 0.218 | -0.060 | ||||
Terminal ileal (L1) | 68 (32.2) | 50 (36.5) | 36 (35.3) | 37 (36.3) | ||
Colonic (L2) | 10 (4.7) | 2 (1.5) | 6 (5.9) | 2 (2.0) | ||
Ileocolic (L3) | 133 (63.0) | 85 (62.0) | 60 (58.8) | 63 (61.8) | ||
Disease duration (mo) | 49.8 ± 50.9 | 68.1 ± 59.3 | 0.003 | 61.5 ± 57.4 | 67.0 ± 57.8 | 0.095 |
Perianal CD | 103 (48.8) | 57 (41.6) | 0.226 | 45 (44.1) | 45 (44.1) | 0.000 |
Family history of CD | 5 (2.4) | 5 (3.6) | 0.523 | 4 (3.9) | 4 (3.9) | 0.000 |
Extra-intestinal CD manifestation | 31 (14.7) | 18 (13.1) | 0.754 | 13 (12.7) | 10 (9.8) | -0.093 |
Comorbidity | 21 (10.0) | 5 (3.6) | 0.036 | 2 (2.0) | 4 (3.9) | 0.116 |
Hypertension | 4 (1.9) | 0 (0.0) | 0.157 | 1 (1.0) | 0 (0.0) | |
Diabetes mellitus | 2 (0.9) | 1 (0.7) | 1.000 | 0 (0.0) | 1 (1.0) | |
Others | 15 (7.1) | 5 (3.6) | 0.239 | 1 (1.0) | 4 (3.9) | |
ASA score, 3-4 | 7 (3.3) | 2 (1.5) | 0.397 | 3 (2.9) | 2 (2.0) | 2 |
Emergency | 17 (8.1) | 9 (6.6) | 0.680 | 6 (5.9) | 7 (6.9) | 0.040 |
Preoperative data | ||||||
Hemoglobin (g/dL) | 11.5 ± 1.5 | 11.5 ± 1.9 | 0.780 | 11.4 ± 1.4 | 11.4 ± 1.8 | 0.037 |
Albumin (g/dL) | 3.1 ± 0.5 | 3.2 ± 0.5 | 0.140 | 3.1 ± 0.5 | 3.2 ± 0.5 | 0.075 |
Transfusion | 40 (19.0) | 26 (19.0) | 1.000 | 22 (21.6) | 20 (19.6) | 2 |
Preoperative medications | ||||||
Steroids | 44 (20.9) | 25 (18.2) | 0.584 | 22 (21.6) | 15 (14.7) | -0.179 |
Immuno-modulators | 96 (45.5) | 67 (48.9) | 0.583 | 48 (47.1) | 50 (49.0) | 0.039 |
Biologics | 29 (13.7) | 26 (19.0) | 0.229 | 17 (16.7) | 16 (15.7) | -0.027 |
Indication for surgery | < 0.001 | |||||
1Fistula versus others | 83 (39.3) | 34 (24.8) | 0.022 | 33 (32.4) | 32 (31.4) | 0.021 |
2Obstruction versus others | 39 (18.5) | 54 (39.4) | < 0.001 | 31 (30.4) | 26 (25.5) | -0.042 |
- Citation: Pak SJ, Kim YI, Yoon YS, Lee JL, Lee JB, Yu CS. Short-term and long-term outcomes of laparoscopic vs open ileocolic resection in patients with Crohn's disease: Propensity-score matching analysis. World J Gastroenterol 2021; 27(41): 7159-7172
- URL: https://www.wjgnet.com/1007-9327/full/v27/i41/7159.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i41.7159